Biotech

All Articles

Galapagos stops CAR-T cell therapy hearing over Parkinsonism case

.Galapagos has stopped briefly application in a test of a BCMA-directed CAR-T cell therapy, pumping ...

James Wilson leaving Penn to introduce pair of brand-new biotechs

.After much more than 30 years, genetics therapy trailblazer James Wilson M.D., Ph.D., is actually l...

3 biotechs attempt to beat the summer season warmth by dropping team

.As biotechs try to transform a fresh web page in August, at least 3 firms have lost personnel in at...

venBio lifts $528M for fifth life scientific researches VC fund

.Veteran financial backing agency venBio has raised one more half a billion dollars to acquire biote...

Otsuka pays $800M for Jnana as well as its own clinical-stage PKU drug

.Otsuka Drug has grabbed Boston-based Jnana Rehabs for $800 million so the Japanese biotech can easi...

FibroGen gives up 75% of US staff as possession flunks 2 even more tests

.FibroGen is actually significantly restructuring its own service, laying off 75% of its own united ...

Tracon relax weeks after injectable PD-L1 inhibitor stop working

.Tracon Pharmaceuticals has chosen to relax functions full weeks after an injectable invulnerable ga...

Ideaya bags possibility on Biocytogen bispecific ADC in $400M deal

.Ideaya Biosciences is betting $400 thousand in biobucks that a bispecific antibody-drug conjugate (...

Takeda takes $140M reduction on neglected epilepsy medicine, promotes FDA run

.Our experts already recognize that Takeda is intending to locate a pathway to the FDA for epilepsy ...

VBI Vaccines apply for personal bankruptcy, finds resource purchase

.Immunology biotech VBI Injections is actually diverting precariously near to the point of no return...